Details for Patent: 6,887,459

Summary for Patent: 6,887,459

Patent landscape, scope, and claims:

Title:	Aerosol composition comprising formoterol
Abstract:	The use of a dry powder comprising (A) formoterol, or a pharmaceutically acceptable salt or solvate thereof, or solvate of said salt, and (B) a pharmaceutically acceptable particulate diluent or carrier in an amount of from 400 .mu.g to 5000 .mu.g per .mu.g of (A) for the preparation of an inhalable medicament for the treatment of chronic obstructive pulmonary disease.
Inventor(s):	Haeberlin; Barbara (Muenchenstein, CH)
Assignee:	Novartis, AG (Basel, CH)
Application Number:	10/148,043
Patent Claim Types: see list of patent claims	Use; Composition; Dosage form;

Drugs Protected by US Patent 6,887,459

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 6,887,459

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	9928311	Nov 30, 1999

PCT Information
PCT Filed	November 28, 2000	PCT Application Number:	PCT/EP00/11894
PCT Publication Date:	June 07, 2001	PCT Publication Number:	WO01/39745

International Family Members for US Patent 6,887,459

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2837401
Australia	769765
Brazil	0015908
Canada	2389349